Company Search:
Advanced Search
Sponsored Links
Cancer Genetics Inc Company Snapshot
Cancer Genetics Inc operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cancer Genetics Inc with three other companies in this sector in the United States: American Shared Hospital Services (2018 sales of $19.71 million ), Psychemedics Corporation ($42.67 million of which 92% was Testing), and Exagen Inc ($32.44 million ).

Sales Analysis. Cancer Genetics Inc reported sales of $27.47 million for the year ending December of 2018. This represents a decrease of 5.7% versus 2017, when the company's sales were $29.12 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cancer Genetics Inc
  Stock Performance Chart for Cancer Genetics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .16
(Figures in U.S. Dollars)
1 Week 43.9%   13 Weeks 67.5%  
4 Weeks -7.1%   52 Weeks -80.6%  
Cancer Genetics Inc Key Data:
  Ticker: CGIX Country: United States
  Exchanges: OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 27,470,000
(Year Ending Jan 2019).
Employees: 242
  Currency: U.S. Dollars Market Cap: 9,400,882
  Fiscal Yr Ends: December Shares Outstanding: 57,816,000
  Share Type: Common Closely Held Shares: 10,099,476
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.